FibroGen Inc is a biopharmaceutical company based in South San Francisco, CA, specializing in the development of innovative therapies for serious and life-threatening diseases. With a focus on pancreatic cancer, prostate cancer, Duchenne muscular dystrophy, and anemia, the company is dedicated to bringing about positive changes in patients' lives through its pipeline of novel products.
Driven by a commitment to responsible development, FibroGen Inc is actively engaged in clinical trials and collaborates with partners to accelerate the introduction of world-class innovations, particularly in China. With a growing team of dedicated professionals, the company strives to foster a culture of innovation and make a global impact in the field of biopharmaceuticals.
Generated from the website